European Archives - Page 1201 of 1313 - European Medical Journal

EMJ

First Patients Enrolled and Dosed in the Pivotal Trial of Phase 3 of the Immunotherapy Tedopi® for Advanced Non-Small Cell Lung Cancer

Paris, February 22nd, 2016, 6:30pm – OSE Pharma SA (ISIN: FR0012127173; Mnémo: OSE), an immunooncology company with a specific immunotherapy…

EMJ

Patient Enrolment Completed in US Phase IIb Study of GrassMATAMPL

Allergy Therapeutics (AIM:AGY), the fully integrated specialty pharmaceutical company specialising in allergy vaccines, today announces it has completed…

EMJ

The E. Coli Anchor: The Achilles Heel of Urinary Tract Infections

NEW vaccines could soon be developed to combat urinary tract infections (UTI), following research that has provided a detailed view of a spring-like…

EMJ

Prostate Cancer Discovery May Lead to New Cancer Treatment

AN EXCITING discovery highlighting a link between two prostate cancer treatments has provided the basis for a potential new therapy. In addition…

EMJ

Overview of a Phase I study of ONO/GS-4059 in relapsed and refractory mature B-cell malignancies

Martin JS Dyer, MA, DPhil, FRCP, FRCPath from the University of Leicester, Leicester, UK, provides an overview of a Phase I study of ONO/GS-4059, a…

EMJ

Norgine Launches XIFAXAN® 200mg (aifaximin-α) for the Treatment of Travellers Diarrhoea in Australia

LONDON, UK, Friday 19 February, 12:00 GMT: Norgine B.V. has today announced that XIFAXAN® 200mg is now available in Australia for the treatment of…

EMJ

Introducing the European Medical Journal 1.1

United Kingdom, February 19, 2016: The first edition of the European Medical Journal is available now, this is the first of four issues new for 2016.

EMJ

Mecca’s Cardiac Hospital Describes How it Copes with the Hajj

Riyadh, Saudi Arabia, 12 February 2016: Mecca’s cardiac hospital has described how it copes with the huge patient influx during the Hajj and…

EMJ

New Drug has Potential for Neuron Preservation in Parkinson’s Disease

IMPROVED treatment for Parkinson’s disease could be on the horizon following successful trials of a new drug that can treat the condition by changing…

EMJ

The Progress in Autism Research You ‘Aut’ To Pay Attention To

GABA, the inhibitory neurotransmitter, has been linked with autism for the first time thanks to recent advances in autism-related research.